Pharma Equity Group A/S

Total Valuation

Pharma Equity Group A/S carries a market capitalization of 88.87M, placing it among publicly traded companies globally. Its enterprise value stands at 201.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Pharma Equity Group A/S currently has 1.23B shares outstanding.

Valuation Ratios

Financial Position

Pharma Equity Group A/S maintains a current ratio of 5.69, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.79, indicating elevated leverage, while an interest coverage ratio of -4.29 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Pharma Equity Group A/S's stock has declined approximately -32.96296% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.10.

Income Statement

EBITDA reached -21.29M, while operating income came in at -21.29M.

Balance Sheet

Pharma Equity Group A/S holds 4.23M in cash and equivalents against 11.05M in total debt, resulting in a net debt position of 6.58M. Total book value stands at 122.76M, with working capital of 40.52M providing operational flexibility.

Cash Flow

Pharma Equity Group A/S produced -22.86M in operating cash flow over the past twelve months.

Dividends & Yields

Stock Splits

Pharma Equity Group A/S's most recent stock split took place on January 27, 2023 with a 1:2 split ratio.

Scores

Pharma Equity Group A/S posts an Altman Z-Score of 6.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.